Juno buys Redox for combo amidst ongoing trial hold fallout fiercebiotech.com/biotech/ju…
1
Small cap MyoKardia up by more than a third on early cardiomyopathy data fiercebiotech.com/biotech/sm…
FDA clears Juno to resume CAR-T trial fiercebiotech.com/biotech/fd…
Last call for speakers: FierceBiotech Drug Development Forum lnkd.in/bEA3ppJ
Pfizer, Novartis, BMS join $45M round for early fibrotic disease startup lnkd.in/bEkSAvA
1
IBM Watson, ADA partner to apply cognitive computing to diabetes clinical and research data fiercemedicaldevices.com/sto…
1
I'm taking on a new role heading up FierceBiotech news coverage--will be keeping a hand in FierceMedicalDevices too. teapaw.org/FierceBiotech/status/7…
'Don’t look back. Something might be gaining on you.' -- Satchel Paige - fiercebiotech.com/don-t-look… by @JohnCBiotech
Medtronic details artificial pancreas plans, as well as Mazor, Qualcomm deals lnkd.in/bPA4tnp
Philips launches at-home senior care sensor system, wins VA grant for next-gen assisted living lnkd.in/btn9JaW
Startup slated to launch injectable, one-year tissue oxygen sensor this year in EU fiercemedicaldevices.com/sto…
1
Intarcia raises $75M, touts final data as it preps to launch once-yearly diabetes drug implant fiercemedicaldevices.com/sto…
Soon-Shiong tries again with NantHealth IPO for up to $92M after whistleblower suit @StacyALawrence fiercemedicaldevices.com/sto…
Siemens rebrands healthcare biz as it seeks to expand, adding services and more molecular Dx lnkd.in/bXkUJ8b
EXCLUSIVE: Celgene, Novartis back $46M Series A in next oncology play from Flexus execs lnkd.in/bYAczke
Dexcom targets Europe as it buys distributor, opens HQ and aims for reimbursement fiercemedicaldevices.com/sto…
Tandem off 20% as it loses insurer to Medtronic for insulin pumps fiercemedicaldevices.com/sto…
VCs hope for Kythera replay with $34M Series A in aesthetics startup fiercemedicaldevices.com/sto…
Stryker buys oncology limb salvage implant upstart for $52M fiercemedicaldevices.com/sto…
Dexcom proposes Class I recall fix, 'on track' with Verily for next-gen glucose monitors fiercemedicaldevices.com/sto…
1
Ortho after the Carlyle takeover: A Q&A with CEO Martin Madaus lnkd.in/bFy7m4g

